Literature DB >> 19144806

High concentrations of manganese in Mueller-Hinton agar increase MICs of tigecycline determined by Etest.

Carlos Fernández-Mazarrasa1, Olav Mazarrasa, Jorge Calvo, Asunción del Arco, Luis Martínez-Martínez.   

Abstract

MICs of tigecycline determined by Etest were 4 to 12 times (three ATCC strains) and 2 to 8 times (50 clinical isolates) higher in Mueller-Hinton agar from Merck than in Mueller-Hinton agar from either Oxoid or Difco. This was related to a much higher concentration of manganese in the medium from Merck.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19144806      PMCID： PMC2650928          DOI： 10.1128/JCM.02464-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Effect of medium age and supplementation with the biocatalytic oxygen-reducing reagent oxyrase on in vitro activities of tigecycline against recent clinical isolates.

Authors:  Peter J Petersen; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

2.  Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin polymyxin B, and carbenicillin.

Authors:  R F D'amato; C Thornsberry; C N Baker; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

3.  Multiplex PCR detection of vanA, vanB, vanC-1, and vanC-2/3 genes in enterococci.

Authors:  R Patel; J R Uhl; P Kohner; M K Hopkins; F R Cockerill
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

4.  Serum concentration of zinc, copper, manganese and magnesium in patients with liver cirrhosis.

Authors:  Dario Rahelić; Milan Kujundzić; Zeljko Romić; Kristina Brkić; Mladen Petrovecki
Journal:  Coll Antropol       Date:  2006-09

5.  Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method.

Authors:  Patricia A Bradford; Peter J Petersen; Mairead Young; C Hal Jones; Mark Tischler; John O'Connell
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

6.  Multiplex PCR for identification of methicillin-resistant staphylococci in the clinical laboratory.

Authors:  D J Geha; J R Uhl; C A Gustaferro; D H Persing
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

7.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

8.  Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosa.

Authors:  M Carmen Conejo; Isabel García; Luis Martínez-Martínez; Leandro Picabea; Alvaro Pascual
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

9.  Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.

Authors:  J Blaser; M N Dudley; D Gilbert; S H Zinner
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

10.  Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.

Authors:  Visanu Thamlikitkul; Surapee Tiengrim
Journal:  J Antimicrob Chemother       Date:  2008-06-21       Impact factor: 5.790
View more
  19 in total

1.  Effect of manganese in test media on in vitro susceptibility of Enterobacteriaceae and Acinetobacter baumannii to tigecycline.

Authors:  J Veenemans; J W Mouton; J A J W Kluytmans; R Donnely; C Verhulst; P H J van Keulen
Journal:  J Clin Microbiol       Date:  2012-06-20       Impact factor: 5.948

2.  Evaluation of Etest to determine tigecycline MICs for Enterobacter species.

Authors:  James Cohen Stuart; Johan W Mouton; Bram M W Diederen; Nashwan Al Naiemi; Steven Thijsen; Bart J M Vlaminckx; Ad C Fluit; Maurine A Leverstein-van Hall
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

Review 3.  Antimicrobial Susceptibility Testing for Polymyxins: Challenges, Issues, and Recommendations.

Authors:  Fereshteh Ezadi; Abdollah Ardebili; Reza Mirnejad
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

4.  Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC.

Authors:  M Torrico; N González; M J Giménez; L Alou; D Sevillano; D Navarro; M P Díaz-Antolín; N Larrosa; L Aguilar; N Garcia-Escribano
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

5.  Cation concentration variability of four distinct Mueller-Hinton agar brands influences polymyxin B susceptibility results.

Authors:  Raquel Girardello; Paulo J M Bispo; Tiago M Yamanaka; Ana C Gales
Journal:  J Clin Microbiol       Date:  2012-05-02       Impact factor: 5.948

6.  Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Peng Wang; Sarah L Bowler; Serena F Kantz; Roberta T Mettus; Yan Guo; Christi L McElheny; Yohei Doi
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

7.  In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains.

Authors:  E J M Verkade; C J M M Verhulst; X W Huijsdens; J A J W Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-26       Impact factor: 3.267

8.  In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest.

Authors:  Chris M Pillar; Deborah C Draghi; Michael J Dowzicky; Daniel F Sahm
Journal:  J Clin Microbiol       Date:  2008-07-02       Impact factor: 5.948

9.  Nuclease activity gives an edge to host-defense peptide piscidin 3 over piscidin 1, rendering it more effective against persisters and biofilms.

Authors:  M Daben J Libardo; Ali A Bahar; Buyong Ma; Riqiang Fu; Laura E McCormick; Jun Zhao; Scott A McCallum; Ruth Nussinov; Dacheng Ren; Alfredo M Angeles-Boza; Myriam L Cotten
Journal:  FEBS J       Date:  2017-09-30       Impact factor: 5.542

10.  Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.

Authors:  Dror Marchaim; Jason M Pogue; Oran Tzuman; Kayoko Hayakawa; Paul R Lephart; Hossein Salimnia; Theresa Painter; Marcus J Zervos; Laura E Johnson; Mary Beth Perri; Pamela Hartman; Rama V Thyagarajan; Sharon Major; Melanie Goodell; Mohamad G Fakih; Laraine L Washer; Duane W Newton; Anurag N Malani; Jason M Wholehan; Lona Mody; Keith S Kaye
Journal:  J Clin Microbiol       Date:  2014-03-05       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.